Helix, a leading population genomics company, is actively building a sustainable model of creating germline clinico-genomic datasets by fully integrating with health systems to implement precision medicine programs at scale as part of routine clinical care. Helix’s industry-leading WES platform (Exome+Ⓡ) combined with consented, OMOP standardized EHR data provides life science partners unparalleled research access to comprehensive, scaled, longitudinal data for precision medicine development